Strömberg N, Karlsson K A
Department of Medical Biochemistry, University of Göteborg, Sweden.
J Biol Chem. 1990 Jul 5;265(19):11244-50.
The binding properties of a strain of Propionibacterium granulosum derived from human skin was investigated with reference to glycosphingolipids separated on thin layer chromatograms or coated in microtiter wells using externally (125I) and metabolically [( 35S]methionine) labeled bacteria. Binding was found to lactosylceramide (LacCer; Gal beta 1-4Glc beta 1-Cer) but not to glycolipids lacking the lactose sequence (i.e. Glc beta 1-Cer, Gal beta 1-Cer or Gal alpha 1-4Gal beta 1-Cer). In microtiter wells, binding occurred at 50 ng and became half-maximal at the theoretical value for a monomolecular layer of LacCer (i.e. 100-200 ng/well). The bacteria also bound to glycolipids with various substitutions (e.g. GalNAc beta 1-4, Gal beta 1-3GalNAc beta 1-4, Fuc alpha 1-2Gal beta 1-3GalNAc beta 1-4, Gal alpha 1-3, GlcNAc beta 1-3, Gal beta 1-3GlcNAc beta 1-3, Gal beta 1-4GlcNAc beta 1-3, and Gal beta 1-3(Fuc alpha 1-4)GlcNAc beta 1-3) at the Gal of LacCer, although only those species with GalNAc beta 1-4 or Gal beta 1-3GalNAc beta 1-4 were as active as LacCer itself. Glycolipids with other additions (e.g. Gal alpha 1-4 and NeuAc alpha 2-3) were negative. For unsubstituted LacCer, the binding required either a trihydroxy base or 2-hydroxy fatty acid, specifying the epithelial type of ceramide; LacCer composed of a dihydroxy base and nonhydroxy fatty acid was negative. This is interpreted as indicating that the proper presentation of the binding epitope depends on the ceramide structure. The relevance of this to biological membranes has not yet been established. Neither free lactose (up to 20 mg/ml) nor lactose-bovine serum albumin (5 mg/ml) prevented the binding of bacteria to LacCer, two facts that support the solid-phase binding data demonstrating a low affinity binding and the crucial importance of a particular lactose epitope.
利用在薄层色谱上分离或包被于微量滴定孔中的糖鞘脂,使用外源性(125I)和代谢性[(35S]甲硫氨酸)标记的细菌,研究了一株源自人皮肤的颗粒丙酸杆菌的结合特性。发现该细菌能与乳糖神经酰胺(LacCer;Galβ1-4Glcβ1-Cer)结合,但不能与缺乏乳糖序列的糖脂(即Glcβ1-Cer、Galβ1-Cer或Galα1-4Galβ1-Cer)结合。在微量滴定孔中,50 ng时发生结合,在LacCer单分子层的理论值(即100 - 200 ng/孔)时达到最大结合量的一半。该细菌还能与LacCer的半乳糖上带有各种取代基的糖脂结合(例如GalNAcβ1-4、Galβ1-3GalNAcβ1-4、Fucα1-2Galβ1-3GalNAcβ1-4、Galα1-3、GlcNAcβ1-3、Galβ1-3GlcNAcβ1-3、Galβ1-4GlcNAcβ1-3以及Galβ1-3(Fucα1-4)GlcNAcβ1-3),尽管只有带有GalNAcβ1-4或Galβ1-3GalNAcβ1-4的糖脂与LacCer本身具有相同的活性。带有其他添加物(例如Galα1-4和NeuAcα2-3)的糖脂则无结合活性。对于未取代的LacCer,结合需要一个三羟基碱基或2-羟基脂肪酸,这确定了上皮型神经酰胺;由二羟基碱基和非羟基脂肪酸组成的LacCer无结合活性。这被解释为表明结合表位的正确呈现取决于神经酰胺结构。其与生物膜的相关性尚未确定。游离乳糖(高达20 mg/ml)和乳糖-牛血清白蛋白(5 mg/ml)均不能阻止细菌与LacCer的结合,这两个事实支持了固相结合数据,表明存在低亲和力结合以及特定乳糖表位的关键重要性。